Elasty® G – High-Density Cross-Linked HA Dermal Filler | 2 × 1ml | Non-Lidocaine *SALE*

Elasty® G – High-Density Cross-Linked HA Dermal Filler | 2 × 1ml | Non-Lidocaine

Product Overview

Elasty® G is the highest-density dermal filler within the Elasty® F/D/G range, developed for advanced facial contouring, deep structural support and significant volume restoration.

Formulated with 24mg/ml cross-linked Hyaluronic Acid (HA), Elasty® G features a dense monophasic gel designed to provide high lifting capacity, strong projection and excellent shape retention for professionally planned structural facial enhancement.

Elasty® G is manufactured using PNET® (Preserved Natural Entanglement Technology), a patented HA-processing technology designed to preserve the natural entanglement of Hyaluronic Acid chains while producing a highly cohesive, elastic and durable injectable gel.

Compared with the softer Elasty® F and medium-density Elasty® D formulations, Elasty® G is positioned towards treatment objectives requiring greater:

• Structural support

• Projection

• Lifting capacity

• Shape retention

• Volume restoration

• Facial definition

Its high-density gel characteristics make Elasty® G particularly suited to advanced facial contouring where substantial tissue support is required rather than superficial wrinkle correction.

Potential professional treatment objectives include:

• Cheek augmentation

• Chin enhancement

• Jawline definition

• Facial contouring

• Deep volume restoration

• Structural facial augmentation

• Correction of selected deep facial folds

• Restoration of age-related structural volume loss

The formulation is designed to provide strong structural performance while maintaining appropriate tissue integration and natural-looking facial proportions.

Elasty® G is intended strictly for use by appropriately qualified medical or aesthetic professionals with suitable training in advanced dermal filler procedures, facial anatomy, vascular anatomy and complication management.

Pack Contents

Each pack contains:

• 2 × 1ml pre-filled syringes of Elasty® G

• Cross-Linked Hyaluronic Acid: 24mg/ml

• Sterile needle(s), as supplied by the manufacturer

• Sterile, sealed professional-use packaging

Volume per Syringe: 1ml

Total Product Volume: 2ml

Always check the individual product packaging, supplied needle specifications, manufacturer labelling and current Instructions for Use before administration.

Product CompositionCross-Linked Hyaluronic Acid – 24mg/ml

Elasty® G contains 24mg/ml highly purified cross-linked Hyaluronic Acid.

The supplied product information describes the HA as non-animal stabilised Hyaluronic Acid developed to provide deep structural support, facial contour enhancement and significant volume restoration.

Cross-linking increases the mechanical stability and persistence of Hyaluronic Acid compared with non-cross-linked HA formulations.

Within Elasty® G, the cross-linked HA gel is designed to support:

• Deep volume restoration

• Facial projection

• Structural tissue support

• Facial contour enhancement

• Shape retention

• Correction of appropriate deeper folds

• Natural-looking facial augmentation

Its high-density characteristics distinguish Elasty® G from softer fillers intended for fine lines or more superficial correction.

PNET® – Preserved Natural Entanglement Technology

Elasty® G is manufactured using PNET® – Preserved Natural Entanglement Technology.

According to the supplied product information, PNET® is designed to preserve the natural structure and entanglement of Hyaluronic Acid while producing a highly cohesive and elastic injectable gel.

The technology is designed to provide:

• High elasticity

• Strong cohesion

• Gel stability

• Durability

• Shape retention

• Lifting capacity

• Smooth tissue integration

• Predictable aesthetic performance

These characteristics are particularly important for a structural filler where the treatment objective requires the product to maintain projection and support following appropriate placement.

High-Density Monophasic HA Gel

Elasty® G features a high-density monophasic Hyaluronic Acid gel.

Its dense gel structure is designed to provide greater mechanical support than the softer formulations within the Elasty® range.

The supplied product information describes Elasty® G as providing:

• High lifting capacity

• Excellent projection

• Strong structural support

• Excellent shape retention

• High elasticity

• Strong cohesion

• Durable contour enhancement

• Smooth tissue integration

These characteristics position Elasty® G towards advanced facial treatments requiring significant support and contour definition.

Deep Structural Support

Elasty® G is designed primarily for structural facial enhancement rather than superficial wrinkle correction.

Age-related changes can involve loss and redistribution of facial volume, changes in skeletal support and alteration of facial contours.

A high-density filler may be selected where the professional treatment objective requires greater mechanical support.

Potential objectives may include:

• Restoration of deeper facial volume

• Enhancement of facial contours

• Improved facial projection

• Support of selected structural areas

• Restoration of age-related contour changes

• Improved facial balance

The treatment plan should always be determined according to individual anatomy and the degree of correction required.

Facial Volume Restoration

Elasty® G is designed to provide significant volume restoration in appropriately selected facial areas.

Potential professional treatment objectives may include:

• Restoring volume to the cheeks

• Supporting mid-face contours

• Improving chin projection

• Enhancing mandibular definition

• Addressing selected temporal volume loss

• Restoring deeper age-related volume deficiencies

The objective should be controlled, anatomically appropriate restoration rather than excessive or unnecessary volume.

Treatment should preserve facial proportions and overall harmony.

Cheek Enhancement

The high-density characteristics of Elasty® G make it suitable for professionally selected cheek and facial contouring treatments where greater support or projection is required.

Potential objectives may include:

• Cheek contour enhancement

• Restoration of age-related volume loss

• Improved mid-face proportions

• Greater facial definition

• Improved facial balance

Product placement, volume and treatment plane must be individually determined according to patient anatomy and the manufacturer's current Instructions for Use.

Chin Enhancement

Elasty® G may be considered for appropriately selected chin treatments where increased projection or structural definition is required.

Potential objectives may include:

• Improved chin projection

• Improved facial profile

• Greater lower-face definition

• Correction of selected asymmetry

• Improved facial proportions

Chin treatment requires detailed understanding of local anatomy, vascular structures and surrounding tissues.

Jawline & Lower-Face Contouring

The strong structural characteristics of Elasty® G may also support professionally planned jawline and lower-face treatments.

Potential treatment objectives may include:

• Improved mandibular definition

• Greater jawline structure

• Lower-face contour enhancement

• Improved facial proportions

• Profile balancing

• Correction of selected contour deficiencies

Appropriate product selection and placement are essential to avoid unnecessary heaviness or overcorrection of the lower face.

Key Benefits

• Highest-density formulation within the Elasty® F/D/G range

• Professional cross-linked HA dermal filler

• 24mg/ml Hyaluronic Acid

• 2 × 1ml pre-filled syringes

• 2ml total product volume

• Manufactured using PNET® technology

• High-density monophasic gel

• High lifting capacity

• Excellent projection

• Strong structural support

• Excellent shape retention

• High elasticity

• Strong cohesion

• Designed for durable facial contour enhancement

• Supports significant volume restoration

• Suitable for selected cheek enhancement

• Suitable for selected chin enhancement

• Suitable for selected jawline contouring

• Supports advanced facial contouring

• Supports correction of selected deep folds

• Designed for natural tissue integration

• Provides immediate physical correction

• Intended strictly for appropriately qualified professional use

Common Treatment Areas

The supplied product information identifies potential treatment areas including:

• Cheeks

• Chin

• Jawline

• Temples

• Deep nasolabial folds

• Facial contouring areas

• Areas requiring structural facial augmentation

Treatment suitability must always be determined according to:

• Manufacturer-authorised indications

• Individual facial anatomy

• Vascular anatomy

• Degree of volume loss

• Tissue thickness

• Required level of projection

• Treatment plane

• Previous aesthetic treatments

• Practitioner competence

• Individual treatment objectives

Some anatomical regions carry greater vascular risk than others and require advanced anatomical knowledge and appropriate professional competence.

Always follow the manufacturer's current Instructions for Use regarding authorised indications, treatment depth, administration technique, product volume and placement.

Elasty® F vs D vs G

The Elasty® F/D/G range provides different gel characteristics for different levels of aesthetic correction.

Elasty® F – Finer Correction

Positioned primarily for:

• Fine lines

• Superficial to moderate wrinkles

• Delicate facial correction

• Subtle lip enhancement

• Lip contour refinement

• Softer, flexible correction

Primary focus: Fine correction and subtle enhancement.

Elasty® D – Balanced Volume & Contouring

Positioned primarily for:

• Moderate to deep wrinkles

• Moderate volume restoration

• Facial contour enhancement

• Cheeks

• Chin

• Jawline

• Lower-face correction

Primary focus: Balanced volume, support and contouring.

Elasty® G – Structural Support & Projection

Positioned primarily for:

• Deep volume restoration

• High lifting requirements

• Facial projection

• Cheek augmentation

• Chin enhancement

• Jawline definition

• Structural facial contouring

Primary focus: Deep structural support, projection and significant volume restoration.

The progression can therefore be considered:

F → Finer / Softer

D → Defined / Balanced

G → Greater Structural Support

The appropriate formulation should always be selected according to anatomy, tissue characteristics, authorised indications and individual treatment objectives.

Elasty® G vs Skin Boosters

Elasty® G should not be considered equivalent to a skin booster or biorevitalisation product.

Skin Boosters

These products generally focus on:

• Hydration

• Moisture retention

• Skin texture

• Elasticity

• General skin-quality improvement

Elasty® G

As a high-density cross-linked dermal filler, Elasty® G is designed primarily to provide:

• Physical volume

• Projection

• Structural support

• Facial contouring

• Lifting capacity

• Shape retention

Its primary objective is therefore structural facial enhancement rather than general skin hydration.

Recommended Treatment Approach

Elasty® G is generally administered as an individually planned dermal filler treatment following comprehensive professional assessment.

The supplied information describes a typical approach as:

• Initial Treatment: Single treatment session

• Review: Approximately 2 weeks following treatment where clinically indicated

• Maintenance: Approximately every 12 months depending upon treatment goals and individual patient factors

These intervals should not be considered a universal protocol or guarantee of product longevity.

Treatment planning should consider:

• Patient anatomy

• Degree of volume loss

• Treatment area

• Tissue characteristics

• Required level of projection

• Previous filler treatments

• Product persistence

• Clinical response

• Individual aesthetic objectives

Additional treatment should only be considered following appropriate professional reassessment.

Professional Treatment Considerations

Elasty® G should only be administered by appropriately qualified and trained medical or aesthetic professionals with suitable competence in advanced dermal filler procedures.

Because the product is positioned for structural augmentation and deeper volume restoration, practitioners should have detailed knowledge of:

• Facial anatomy

• Vascular anatomy

• Deep facial fat compartments

• Appropriate treatment planes

• Structural facial assessment

• Dermal filler rheology

• Patient selection

• Aseptic technique

• Vascular complication prevention

• Recognition of vascular compromise

• Emergency management

• Dermal filler complication management

Treatment planning should include:

• Comprehensive patient consultation

• Full medical history

• Detailed facial assessment

• Assessment of facial proportions

• Assessment of structural volume loss

• Evaluation of tissue characteristics

• Evaluation of vascular anatomy

• Review of previous filler treatments

• Assessment of contraindications

• Discussion of realistic treatment expectations

• Explanation of potential complications

• Appropriate documented informed consent

Treatment depth, technique, product volume and distribution should always be determined according to individual anatomy, treatment objectives and the manufacturer's current Instructions for Use.

Results & Treatment Outcomes

Elasty® G provides immediate structural volume and contour enhancement following appropriate professional placement.

Potential outcomes may include:

• Restored facial volume

• Enhanced cheek contours

• Improved chin projection

• Improved jawline definition

• Greater facial structure

• Improved facial proportions

• Improved profile balance

• Correction of selected deep facial folds

• Natural-looking structural rejuvenation

Initial treatment-related swelling may temporarily influence the appearance of the treated area.

The final aesthetic outcome becomes clearer as swelling resolves and the filler integrates within the surrounding tissues.

Results & Longevity

The supplied product information describes typical clinical longevity as:

Approximately 12 months or longer

This should be considered an approximate range rather than a guaranteed duration.

Individual persistence can vary according to:

• Treatment area

• Product volume

• Treatment technique

• Treatment depth

• Patient metabolism

• Facial movement

• Tissue characteristics

• Patient age

• Lifestyle

• Individual biological response

Less mobile structural treatment areas may demonstrate different persistence compared with highly mobile facial regions.

Maintenance treatment may subsequently be considered following professional reassessment.

Shape Retention & Projection

One of the defining characteristics of a high-density structural filler is its ability to maintain the intended shape and projection following appropriate placement.

Elasty® G is designed to provide strong shape retention while integrating appropriately within the treated tissues.

This may be particularly important when treating areas where the objective involves:

• Projection

• Definition

• Structural support

• Contour creation

• Volume restoration

The degree of correction should always remain appropriate to the patient's natural facial anatomy and proportions.

Storage & Handling

Elasty® G should be stored and handled according to the manufacturer's current Instructions for Use and information supplied with the original product.

To maintain product integrity:

• Keep the product within its original packaging until required.

• Follow the manufacturer's specified storage conditions.

• Protect from inappropriate environmental exposure.

• Inspect each syringe and outer packaging before use.

• Check the batch number and expiry date.

• Verify product authenticity and traceability.

• Maintain appropriate aseptic handling procedures.

• Do not use if sterile packaging is damaged.

• Do not use if a syringe appears compromised.

• Do not use after the stated expiry date.

Each syringe is intended for single use according to the manufacturer's Instructions for Use.

Important Information

Elasty® G is intended strictly for use by appropriately qualified and trained medical or aesthetic professionals.

Professional knowledge of advanced facial anatomy, vascular anatomy, dermal filler techniques and complication management is essential.

Patient Assessment

Treatment should only proceed following:

• Full patient consultation

• Comprehensive medical history

• Detailed facial assessment

• Examination of the proposed treatment area

• Assessment of facial proportions

• Assessment of volume loss

• Review of previous aesthetic treatments

• Assessment of contraindications

• Discussion of realistic treatment expectations

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Contraindications & Precautions

The supplied information does not provide a complete manufacturer-defined contraindication list.

Practitioners should therefore consult the current Elasty® G Instructions for Use for the complete contraindications, warnings and precautions applicable to the product.

Treatment should not proceed where product sterility, integrity, authenticity or traceability cannot be established.

Potential Treatment Reactions

Temporary effects associated with injectable dermal filler procedures may include:

• Redness

• Swelling

• Bruising

• Tenderness

• Discomfort

• Localised firmness

• Temporary contour irregularity

The precise adverse-event profile should be confirmed from the manufacturer's current Instructions for Use.

Serious Dermal Filler Complications

Injectable dermal filler procedures can result in more significant complications.

Potential serious complications can include infection, inflammatory reactions and vascular events.

Inadvertent intravascular administration may result in vascular occlusion and serious tissue injury. Depending upon the anatomical region involved, vascular filler complications can have severe consequences.

Practitioners must therefore have appropriate knowledge of facial vascular anatomy and be competent in:

• Risk reduction

• Early recognition of vascular compromise

• Appropriate emergency response

• Dermal filler complication management

Patients should receive appropriate written aftercare information and clear instructions regarding symptoms requiring urgent professional assessment.

Always consult the manufacturer's current Instructions for Use for complete information regarding indications, contraindications, warnings, precautions, administration and potential adverse events.

For appropriately qualified professional use only.